+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Omics Lab Services Market Size, Share & Industry Trends Analysis Report By Business (Diagnostic Labs, Research Institutes, and Hospitals), By End Use, By Type, By Product, By Frequency of Service, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 95 Pages
  • December 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5723935
The North America Omics Lab Services Market should witness market growth of 12.4% CAGR during the forecast period (2022-2028).

The Omics research has mostly helped the area of cancer, and one recently established use of NGS clinical testing is for the measurement of circulating tumor DNA (ctDNA) from plasma. There are several NGS technologies that may be applied, including Cancer Personalized Profiling by deep sequencing. Recent advancements in high-throughput RNA sequencing have highlighted the significance of transcriptomics in biological and clinical research. Transcriptomics may be carried out utilizing microarrays or RNA sequencing using NGS technology.

Omics labs have become an essential tool for the prognosis, diagnosis, and treatment of a wide range of diseases; however, the sample sent to omics labs are significantly impacted by supply chain and logistics issues, a lack of skilled professionals with the capacity to handle samples and these issues. Tens of thousands to millions of molecular measurements may be found in omics databases.

Usually, researchers begin by making feature selection, which entails selecting a subset of the data that seem to be connected to the characteristic or outcome or that are presumed to be physiologically relevant based on prior experience. Using just this subset of the data, a fully described computer model may be developed to forecast the clinical outcome based on the omics measurements.

North America is witnessing a massive adoption of new sequencing technology and a shift toward tailored medications. In addition, government assistance is critical. For example, the Biden Administration announced a USD 1.7 billion investment to Fight COVID-19 Variants in April 2021, with USD 1 billion going to expand genomic sequencing and USD 400 million going to support innovation initiatives like the launch of new innovative centers of excellence in genomic epidemiology.

The US market dominated the North America Omics Lab Services Market by Country in 2021; thereby, achieving a market value of $37.6 billion by 2028. The Canada market is anticipated to grow at a CAGR of 15% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 13.9% during (2022-2028).

Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience

Scope of the Study

By Business

  • Diagnostic Labs
  • Research Institutes
  • Hospitals

By End-Use

  • Cancer
  • Pharmaco
  • Population Studies & Genealogy
  • Reproductive
  • Skincare
  • Nutrition, Vitamin & Supplements
  • Forensics & Others

By Type

  • Proteomics
  • Transcriptomic
  • Metabolomics
  • Genomics
  • Epigenetics

By Product

  • Hardware Equipment
  • Testing / Lab Services
  • Analytics / Interpretation

By Frequency of Service

  • Continuous
  • Repeat
  • One-off

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • BGI Group
  • Q2 Solutions (IQVIA)
  • Flomics Biotech
  • PhenoSwitch Bioscience

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Omics Lab Services Market, by Business
1.4.2 North America Omics Lab Services Market, by End-Use
1.4.3 North America Omics Lab Services Market, by Type
1.4.4 North America Omics Lab Services Market, by Product
1.4.5 North America Omics Lab Services Market, by Frequency of Service
1.4.6 North America Omics Lab Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Omics Lab Services Market
Chapter 4. North America Omics Lab Services Market by Business
4.1 North America Diagnostic Labs Market by Country
4.2 North America Research Institutes Market by Country
4.3 North America Hospitals Market by Country
Chapter 5. North America Omics Lab Services Market by End-Use
5.1 North America Cancer Market by Country
5.2 North America Pharmaco Market by Country
5.3 North America Population Studies & Genealogy Market by Country
5.4 North America Reproductive Market by Country
5.5 North America Skincare Market by Country
5.6 North America Nutrition, Vitamin & Supplements Market by Country
5.7 North America Forensics & Others Market by Country
Chapter 6. North America Omics Lab Services Market by Type
6.1 North America Proteomics Market by Country
6.2 North America Transcriptomic Market by Country
6.3 North America Metabolomics Market by Country
6.4 North America Genomics Market by Country
6.5 North America Epigenetics Market by Country
Chapter 7. North America Omics Lab Services Market by Product
7.1 North America Hardware Equipment Market by Country
7.2 North America Testing / Lab Services Market by Country
7.3 North America Analytics / Interpretation Market by Country
Chapter 8. North America Omics Lab Services Market by Frequency of Service
8.1 North America Continuous Market by Country
8.2 North America Repeat Market by Country
8.3 North America One-off Market by Country
Chapter 9. North America Omics Lab Services Market by Country
9.1 US Omics Lab Services Market
9.1.1 US Omics Lab Services Market by Business
9.1.2 US Omics Lab Services Market by End-Use
9.1.3 US Omics Lab Services Market by Type
9.1.4 US Omics Lab Services Market by Product
9.1.5 US Omics Lab Services Market by Frequency of Service
9.2 Canada Omics Lab Services Market
9.2.1 Canada Omics Lab Services Market by Business
9.2.2 Canada Omics Lab Services Market by End-Use
9.2.3 Canada Omics Lab Services Market by Type
9.2.4 Canada Omics Lab Services Market by Product
9.2.5 Canada Omics Lab Services Market by Frequency of Service
9.3 Mexico Omics Lab Services Market
9.3.1 Mexico Omics Lab Services Market by Business
9.3.2 Mexico Omics Lab Services Market by End-Use
9.3.3 Mexico Omics Lab Services Market by Type
9.3.4 Mexico Omics Lab Services Market by Product
9.3.5 Mexico Omics Lab Services Market by Frequency of Service
9.4 Rest of North America Omics Lab Services Market
9.4.1 Rest of North America Omics Lab Services Market by Business
9.4.2 Rest of North America Omics Lab Services Market by End-Use
9.4.3 Rest of North America Omics Lab Services Market by Type
9.4.4 Rest of North America Omics Lab Services Market by Product
9.4.5 Rest of North America Omics Lab Services Market by Frequency of Service
Chapter 10. Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 Agilent Technologies, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.3 Qiagen N.V.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.4 Quest Diagnostics Incorporated
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 Recent strategies and developments:
10.4.4.1 Acquisition and Mergers:
10.5 Illumina, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 BGI Group
10.6.1 Company Overview
10.7 Q2 Solutions (IQVIA)
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Partnerships, Collaborations, and Agreements:
10.8 Flomics Biotech
10.8.1 Company Overview
10.9 PhenoSwitch Bioscience
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • BGI Group
  • Q2 Solutions (IQVIA)
  • Flomics Biotech
  • PhenoSwitch Bioscience

Methodology

Loading
LOADING...